{"id":51165,"date":"2022-11-22T23:02:33","date_gmt":"2022-11-22T22:02:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/"},"modified":"2022-11-22T23:02:33","modified_gmt":"2022-11-22T22:02:33","slug":"conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/","title":{"rendered":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference"},"content":{"rendered":"<div>\n<p>LARGO, Fla.&#8211;(BUSINESS WIRE)&#8211;<b>CONMED Corporation (NYSE: CNMD)<\/b> today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34<sup>th<\/sup> Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/5\/ConMed_LogoPMS3005_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg\"><\/a><\/p>\n<p>\nA live audio webcast of the fireside chat will be accessible through the \u201cInvestors\u201d section of the Company\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.conmed.com&amp;esheet=52977151&amp;newsitemid=20221122005829&amp;lan=en-US&amp;anchor=www.conmed.com&amp;index=1&amp;md5=625f7fbc42d5091358f674f03b687a53\" rel=\"nofollow noopener\" shape=\"rect\">www.conmed.com<\/a> and will be available for replay following the event.\n<\/p>\n<p>\n<b>About CONMED Corporation<\/b>\n<\/p>\n<p>\nCONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company\u2019s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.conmed.com&amp;esheet=52977151&amp;newsitemid=20221122005829&amp;lan=en-US&amp;anchor=www.conmed.com&amp;index=2&amp;md5=4ed6c62523828a8882c9e9b08bfff7ed\" rel=\"nofollow noopener\" shape=\"rect\">www.conmed.com<\/a>.\n<\/p>\n<p>\n<b>Forward-Looking Statements<\/b>\n<\/p>\n<p>\nThis press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company\u2019s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company&#8217;s Annual Report on Form 10-K for the full year ended December 31, 2021, listed under the heading Forward-Looking Statements in the Company\u2019s most recently filed Form 10-Q, and the risks associated with the timing and costs related to the software implementation as further described in the risk factors listed in the Current Report filed on Form 8-K on November 15, 2022. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company\u2019s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management\u2019s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b><i>CONMED Corporation<\/i><\/b><br \/><b>Todd W. Garner<\/b><br \/><b>Chief Financial Officer<\/b><br \/><b>727-214-2975<\/b><br \/><b><a target=\"_blank\" href=\"&#x6d;&#97;&#105;l&#x74;&#x6f;&#58;T&#x6f;&#x64;&#100;G&#x61;&#x72;&#110;e&#x72;&#x40;&#99;o&#x6e;&#x6d;&#101;d&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x54;o&#x64;&#100;&#x47;&#97;r&#x6e;e&#x72;&#64;&#x63;&#111;n&#x6d;&#101;&#x64;&#46;c&#x6f;m<\/a><\/b>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LARGO, Fla.&#8211;(BUSINESS WIRE)&#8211;CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51165","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LARGO, Fla.&#8211;(BUSINESS WIRE)&#8211;CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T22:02:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference\",\"datePublished\":\"2022-11-22T22:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/\"},\"wordCount\":434,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005829\\\/en\\\/836941\\\/21\\\/ConMed_LogoPMS3005_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/\",\"name\":\"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005829\\\/en\\\/836941\\\/21\\\/ConMed_LogoPMS3005_RGB.jpg\",\"datePublished\":\"2022-11-22T22:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005829\\\/en\\\/836941\\\/21\\\/ConMed_LogoPMS3005_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005829\\\/en\\\/836941\\\/21\\\/ConMed_LogoPMS3005_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend","og_description":"LARGO, Fla.&#8211;(BUSINESS WIRE)&#8211;CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 34th Annual Piper Sander Healthcare Conference at 3:30 p.m. ET on Wednesday, November 30, 2022. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-22T22:02:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference","datePublished":"2022-11-22T22:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/"},"wordCount":434,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/","name":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg","datePublished":"2022-11-22T22:02:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221122005829\/en\/836941\/21\/ConMed_LogoPMS3005_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/conmed-corporation-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sander-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CONMED Corporation to Participate in a Fireside Chat at the 34th Annual Piper Sander Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51165"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51165\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}